Novartis AG
SWX:NOVN
CHF 75.98
+ CHF0.45 (0.60%)
CHF 75.98
+ CHF0.45 (0.60%)
End-of-day quote: 10/03/2022

NOVN - Novartis Stock Prediction 2025 - 2030

20 years of reliable Novartis stock forecast. The Wall Street analysts predict Hold for NOVN. See at a glance whether SWX:NOVN will rise in the future.

CHF97.13
Forecast 2022
CHF121.70
Forecast 2025
CHF163.56
Forecast 2030
Neutral
TopGraphs Quality Ranking
Forecast 2022
CHF97.13
Forecast 2025
CHF121.70
Forecast 2030
CHF163.56
TopGraphs Quality Ranking
Neutral

Novartis Stock Forecast 2022

CHF89.07

In the last five quarters, Novartis's Price Target has fallen from CHF122.56 to CHF103.75 - medium decrease of -15.35%. Ten analysts expect Novartis's share price to fall moderately in the coming year and give 89.07 as a price target. This would correspond to an decrease of -14.15%.

17.23%
17.23

Highest Price Target CHF110.03

Average Price Target CHF89.07

Lowest Price Target CHF63.03

Novartis Stock Predictions 2025

Stock Forecast for the Price of an Novartis Share in Jan 2025.

In January 2025, analysts believe the stock price will be CHF116.29. An increase of 53.05% compared to the previous month's estimate.

Stock Forecast for the Price of an Novartis Share in Feb 2025.

In February 2025, analysts believe the stock price will be CHF116.78. An increase of 53.69% compared to the previous month's estimate.

Stock Forecast for the Price of an Novartis Share in Mar 2025.

In March 2025, analysts believe the stock price will be CHF117.27. An increase of 54.34% compared to the previous month's estimate.

Stock Forecast for the Price of an Novartis Share in Apr 2025.

In April 2025, analysts believe the stock price will be CHF117.76. An increase of 54.99% compared to the previous month's estimate.

Stock Forecast for the Price of an Novartis Share in May 2025.

In May 2025, analysts believe the stock price will be CHF118.25. An increase of 55.64% compared to the previous month's estimate.

Stock Forecast for the Price of an Novartis Share in Jun 2025.

In June 2025, analysts believe the stock price will be CHF118.75. An increase of 56.28% compared to the previous month's estimate.

Stock Forecast for the Price of an Novartis Share in Jul 2025.

In July 2025, analysts believe the stock price will be CHF119.24. An increase of 56.93% compared to the previous month's estimate.

Stock Forecast for the Price of an Novartis Share in Aug 2025.

In August 2025, analysts believe the stock price will be CHF119.73. An increase of 57.58% compared to the previous month's estimate.

Stock Forecast for the Price of an Novartis Share in Sep 2025.

In September 2025, analysts believe the stock price will be CHF120.22. An increase of 58.23% compared to the previous month's estimate.

Stock Forecast for the Price of an Novartis Share in Oct 2025.

In October 2025, analysts believe the stock price will be CHF120.71. An increase of 58.87% compared to the previous month's estimate.

Stock Forecast for the Price of an Novartis Share in Nov 2025.

In November 2025, analysts believe the stock price will be CHF121.21. An increase of 59.52% compared to the previous month's estimate.

Stock Forecast for the Price of an Novartis Share in Dec 2025.

In December 2025, analysts believe the stock price will be CHF121.70. An increase of 60.17% compared to the previous month's estimate.

Novartis Stock Prediction 2030

Stock Prediction for the Price of One Novartis Share in Jan 2030.

In Jan 2030 analysts predict a share price of CHF155.65. An increase of 104.86% compared to today's share price.

Stock Prediction for the Price of One Novartis Share in Feb 2030.

In Feb 2030 analysts predict a share price of CHF156.37. An increase of 105.81% compared to today's share price.

Stock Prediction for the Price of One Novartis Share in Mar 2030.

In Mar 2030 analysts predict a share price of CHF157.09. An increase of 106.75% compared to today's share price.

Stock Prediction for the Price of One Novartis Share in Apr 2030.

In Apr 2030 analysts predict a share price of CHF157.81. An increase of 107.7% compared to today's share price.

Stock Prediction for the Price of One Novartis Share in May 2030.

In May 2030 analysts predict a share price of CHF158.53. An increase of 108.64% compared to today's share price.

Stock Prediction for the Price of One Novartis Share in Jun 2030.

In Jun 2030 analysts predict a share price of CHF159.25. An increase of 109.59% compared to today's share price.

Stock Prediction for the Price of One Novartis Share in Jul 2030.

In Jul 2030 analysts predict a share price of CHF159.97. An increase of 110.54% compared to today's share price.

Stock Prediction for the Price of One Novartis Share in Aug 2030.

In Aug 2030 analysts predict a share price of CHF160.68. An increase of 111.48% compared to today's share price.

Stock Prediction for the Price of One Novartis Share in Sep 2030.

In Sep 2030 analysts predict a share price of CHF161.40. An increase of 112.43% compared to today's share price.

Stock Prediction for the Price of One Novartis Share in Oct 2030.

In Oct 2030 analysts predict a share price of CHF162.12. An increase of 113.37% compared to today's share price.

Stock Prediction for the Price of One Novartis Share in Nov 2030.

In Nov 2030 analysts predict a share price of CHF162.84. An increase of 114.32% compared to today's share price.

Stock Prediction for the Price of One Novartis Share in Dec 2030.

In Dec 2030 analysts predict a share price of CHF163.56. An increase of 115.27% compared to today's share price.

Company Info

P/E Ratio
15.9
Beta
0.49
Price-to-book Ratio
2.64
Market Cap
165.85B
TEV
200.500 B
LT Debt/Cap
0.03%
Dividend
CHF3.12
Div Yld
4.10%
Forecast 1Y
39.73%
Forecast 2Y
55.28%
Analyst Price Target
CHF103.75
Website

About Novartis

Novartis AG researches, develops, manufactures, and markets healthcare products worldwide.

Novartis Price Chart

1M 3M YTD 1Y 2Y 5Y 10Y 20Y
P/E Ratio
15.9
Beta
0.49
Price-to-book Ratio
2.64
Market Cap
165.85B
TEV
200.500 B
LT Debt/Cap
0.03%
Dividend
CHF3.12
Div Yld
4.10%
Forecast 1Y
39.73%
Forecast 2Y
55.28%
Analyst Price Target
CHF103.75
Website

Financials

Year Year 2020 2021
Rev. Revenue
49898.00 52877.00
GM % Gross Margin %
71.1 70.8
OI Operating Income
12187.00 12043.00
OM Operating Margin
24.42 22.78
NI Net Income
8072.00 24021.00
EPS % Earnings Per Share %
5.78 6.29
Div. Dividends
3.39 3.39
PR % Payout Ratio %
58.65 53.90
Sha. Shares
2257 2235
OCF Operating Cash Flow
13650 15071
CS Cap Spending
-2257 -1378
FCF Free Cash Flow
11393 13693
FCFS Free Cash Flow Per Share
5.03 5.73

Novartis Analyst Ratings Frequently Asked Questions

Who are the analysts watching Novartis AG?

The following analysts have recently covered Novartis:

Argus Research Company
Axia Financial Research
Barclays
Berenberg
BNP Paribas Exane
BofA Global Research
Bryan Garnier & Co
Capital Alpha Partners, LLC
CFRA Equity Research
Citigroup Inc
Citigroup Inc. Research
CLSA
Cowen and Company
Day By Day
Deutsche Bank
Goldman Sachs
Guggenheim Securities, LLC
HSBC
J.P. Morgan
Jefferies LLC
Kepler Cheuvreux
Liberum
Marktfeld
Mirabaud Securities LLP
Moody’s
Morgan Stanley
Morningstar Inc.
ODDO BHF Corporate & Markets
Redburn
S&P Global Ratings
Sanford C. Bernstein & Co., LLC
Societe Generale Cross Asset Research
Stifel
UBS Investment Bank
Wolfe Research, LLC.
Zürcher Kantonalbank
Foveal LLP
Oppenheimer & Co. Inc.
Probes Reporter LLC
(This information refers to the last 90 days.)

Who are the sell-side analysts watching Novartis AG?

The following sell-side analysts have recently covered Novartis:

Hellweg, Jasper
Spagna, Fabrizio
Field, Emily
Holford, Kerry Ann
Parkes, Richard J.
Parry, Graham Glyn Charles
Le Fur, Jean-Jacques
Monk, Kimberly D.
Nurhayati, Wan
Baum, Andrew Simon
Scala, Stephen Michael
Vinerier, Jerome
Papadakis, Emmanuel Douglas
Parekh, Keyur
Fernandez, Seamus Christopher
Mead, Julie
Vosser, Richard
Welford, Peter James
Evans, David Paul
Paraskevopoulos, Michail
Chiriano, Gianpaolo
Purcell, Mark Douglas
Conover, Damien
Baker, Simon P.
Boudella, Sabrine
Kapadia, Wimal
Cespedes, Florent
Le Berrigaud, Eric
Anderson, Timothy Minton
Roy, Amit
Thomason, Edward
Paine, Andrew
Jones, Jeffrey Michael
Gavin, John P.
Leuchten, Michael
Kumaar, Mohit
Choplain, Damien
Züger, Philippe
(This information refers to the last 90 days.)

© Copyright 2022 | TopGraphs™ | All Rights Reserved

To use TopGraphs™, you must accept our Terms and Conditions and Privacy Policy